This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biopsy Devices Market Is Expected To Reach USD 2.1 Billion Globally In 2018: Transparency Market Research

ALBANY, New York, March 26, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( " Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems)  -  Global Industry Analysis, Size, Sha re, Growth, Trends and Forecast, 2012  -  2018, " in 2011, the global biopsy devices market was valued at USD 1.3 billion and is expected to grow at a CAGR of 6.6% from 2012 to 2018, to reach an estimated value of USD 2.1 billion in 2018.

Browse the full report at

The market is driven mainly by rising worldwide cancer incidence, increasing preference for minimally invasive procedures and growing awareness regarding frequent screenings. People are more aware regarding development of cancer and its early diagnosis, thereby opting for regular screenings and check-ups. The demand for disposable devices and needles is on the rise, as patients are now highly conscious about issues such as transmission of infectious diseases. Cancer being a fatal disease if not diagnosed early, patients do not hesitate to opt for expensive surgeries. All these factors are expected to drive the growth of the market during the forecast period 2012 to 2018.

Related & Recently Published Reports by Transparency Market Research

Needle-based guns are identified as the fastest growing segment with a CAGR of 8%. Within this segment, preference for vacuum-assisted biopsy devices is higher due to its high efficiency and minimally invasive nature. The biopsy guidance systems segment accounted for the largest market share in 2011; the market for these devices was valued at USD 607.5 million. This segment is expected to continue to lead the market till 2018, in terms of revenue.

Geographically, North America accounted for the largest share in this market in 2011. This is mainly due to the large patient population, availability of advanced medical technologies and strong presence of leading market players. However, with a healthy CAGR of 10.5%, Asia is expected to emerge as the fastest growing regional market on account of the rapidly growing overall population as well as aging population, increasing incidence of cancer, rising disposable incomes of patients and growing economies.

Related & Recently Published Reports by Transparency Market Research

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs